A survival analysis of idiopathic pulmonary fibrosis in the context of antifibrotic therapy in Saudi Arabia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A survival analysis of idiopathic pulmonary fibrosis in the context of antifibrotic therapy in Saudi Arabia

Published:2023 Issue:2 Volume:18 Page:79
ISSN:1817-1737
Container-title:Annals of Thoracic Medicine
language:en
Short-container-title:Ann Thorac Med

Author:

Al-Jahdali Hamdan,Khan MohammedAyaz,Al Ghamdi Basma,Alhamadi Mohammed,Rajendram Rajkumar,Alyami Sami,Al-Gamedi Majed,Al-Harbi Abdullah

Publisher

Medknow

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference26 articles.

1. Nintedanib and pirfenidone.New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions;Raghu;Am J Respir Crit Care Med,2015

2. Diagnosis of idiopathic pulmonary fibrosis.An official ATS/ERS/JRS/ALAT clinical practice guideline;Raghu;Am J Respir Crit Care Med,2018

3. Evaluation and management of idiopathic pulmonary fibrosis;Kishaba;Respir Investig,2019

4. Diagnostic and treatment standards in idiopathic pulmonary fibrosis in the era of antifibrotic drugs in Poland: A real-world practice survey;Majewski;Adv Respir Med,2019

5. Survival and course of lung function in the presence or absence of antifibrotic treatment in patients with idiopathic pulmonary fibrosis: Long-term results of the INSIGHTS-IPF registry;Behr;Eur Respir J,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP